Neoplasms
Conditions
Interventions
Pharmacists will provide patient education in accordance with the randomized allocation.
Patient education by pharmacists
Sponsors
Suzuki Koji
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be included: Age 18 years or older Scheduled to receive treatment with a regimen that includes the drugs specified in Section 4.4 of the study protocol Able to provide written informed consent by signing the consent form
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will be excluded from this study: Patients who are not independent in activities of daily living (ADL) Patients who are unable to communicate Patients for whom study evaluation is difficult due to underlying disease or comorbidities Patients for whom participation is difficult due to neurological or psychiatric disorders Patients who received their first course of chemotherapy as inpatients and are scheduled to receive the second course as inpatients as well Patients presenting with significant skin disorders at the time of enrollment due to prior treatment Patients with a performance status of 2 or higher Patients deemed inappropriate by the attending physician or the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-implementation rates in each group after pharmacist-led instruction on skin disorder management and their confidence intervals. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Difference in self-implementation rates between the two groups after pharmacist-led instruction on skin disorder management and their confidence intervals 2. Changes in VAS scores reflecting willingness for self-implementation of skin disorder avoidance behaviors, obtained from the questionnaire, and their confidence intervals 3. Incidence and severity of skin disorders 4. Self-purchase rates of moisturizers in each group when they were not prescribed by the medical institution 5. Self-implementation rates in each group, along with their confidence intervals, for each item of the primary endpoint criteria (as specified in Section 4.4 of the study protocol) | — |
Contacts
Public ContactKoji Suzuki
Hamamatsu University School of Medicine
Outcome results
None listed